Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Schedule of Summarizes Information About Stock Options (Details)

v3.20.1
Stock-Based Compensation - Schedule of Summarizes Information About Stock Options (Details) - $ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
2014 Long Term Incentive Equity Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Stock Options Outstanding, Beginning Balance 3,327,140 1,936,924
Number of Stock Options, Granted 1,925,000 1,585,324
Number of Stock Option, Exercised
Number of Stock Option, Forfeited (48,611) (195,108)
Number of Stock Options Outstanding, Ending Balance 5,203,529 3,327,140
Number of Stock Options Vested and exercisable 3,270,487 1,620,310
Weighted Average Exercise Price, Beginning Balance $ 3.68 $ 5.19
Weighted Average Exercise Price, Granted 1.00 2.01
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited 5.00 5.00
Weighted Average Exercise Price, Ending Balance 2.68 3.68
Weighted Average Exercise Price, Vested and exercisable $ 3.45 $ 4.40
Remaining Contractual Term (Years), Vested and exercisable stock options 8 years 1 month 6 days 8 years 3 months 19 days
Remaining Contractual Term (Years), Unvested stock options 7 years 6 months 7 years 9 months 18 days
2018 Stock Plan [Member] | Lucid Diagnostics Inc [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Stock Options Outstanding, Beginning Balance 375,000
Number of Stock Options, Granted 620,000 375,000
Number of Stock Option, Exercised
Number of Stock Option, Forfeited
Number of Stock Options Outstanding, Ending Balance 995,000 375,000
Number of Stock Options Vested and exercisable 507,495 87,500
Number of Stock Options Unvested 487,505 287,500
Weighted Average Exercise Price, Beginning Balance $ 0.60  
Weighted Average Exercise Price, Granted 1.02 $ 0.60
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited  
Weighted Average Exercise Price, Ending Balance 0.86 0.60
Weighted Average Exercise Price, Vested and exercisable 0.83 0.57
Weighted Average Exercise Price, Unvested $ 0.89 $ 0.61
Remaining Contractual Term (Years), Vested and exercisable stock options 9 years 9 years 4 months 24 days
Remaining Contractual Term (Years), Unvested stock options 8 years 10 months 25 days 9 years 4 months 24 days